Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?

Clarkson, Thomas B. DVM; Karas, Richard H. MD, PhD

doi: 10.1097/gme.0b013e318157ac70

Wake Forest University School of Medicine, Winston-Salem, NC. Tufts University School of Medicine, Molecular Cardiology Research Center, Preventive Cardiology Center, Women's Heart Center, Boston, MA

Financial disclosure: Dr. Clarkson is a member of the Scientific Advisory Board for Wyeth Pharmaceuticals. Dr. Karas has received consulting fees from Wyeth Pharmaceuticals.

©2007The North American Menopause Society